Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-20-061713

Chief Financial Officer sold 10,000 shares at an average $151.46 ($1,514,612)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McAnear Justin J. · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-01 Exercise or conversion : show line 1 in the form +10,000 $5.04 $50,400 10,933 D
2020-12-01 Sale : show line 2 in the form −2,624 $150.03 $393,680 8,309 D
2020-12-01 Sale : show line 3 in the form −3,168 $150.94 $478,186 5,141 D
2020-12-01 Sale : show line 4 in the form −1,600 $151.80 $242,883 3,541 D
2020-12-01 Sale : show line 5 in the form −2,108 $153.21 $322,965 1,433 D
2020-12-01 Sale : show line 6 in the form −500 $153.79 $76,897 933 D
Open-market sales · 10,000 sh · avg $151.46 · $1,514,612

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-12-01 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −10,000 $5.04 2028-11-02 10,000 500,000 D
Loading xslF345X03/doc4.xml…